Today's top medical abstracts
Internal Med
Become a Member Today!
Email
Password
Remember me
Forgot your Password?

Invite Code?

Home
General Internal Med
Messages
Conferences
Jobs
Newsletters
My Library
Topics in
Internal Med
        Academic Med/Education
        Adolescent Medicine
        Allergy/Immunology
        Atherosclerosis/Lipids
        Basic Science/Genetics
        Cardiology
        Clinical Pharmacology
        Complementary Medicine
        Critical Care/
    Hospitalist
        Dermatology
        Economics of Medicine
        Endocrinology
        Epidemiology
        Gastroenterology
        Geriatrics
        Hematology/Oncology
        Infectious Disease
        Nephrology/Urology
        Neurology
        Orthopedic/Physical Med
        Popular Press
        Preventive Medicine
        Psychiatry
        Pulmonology
        Radiology/Diagnostics
        Rheumatology
        Sports Medicine
        Vascular Medicine
        Women`s Health
 
Help
Resource Center
RSS News Feeds
Send Newsletter
to a Friend
 
Sponsor
Cancer Science: #14. Does Size Matter? "Stumpy" Telomeres Allow Cancer Cells to Evade Senescence
Sara Hartley, MDLinx Oncology
  See all
Risk of Colorectal Cancer Article Summary

Click the title below to leave the MDLinx Network and go to the Journal's Website
Proton pump inhibitors and the risk of colorectal cancer
American Journal of Gastroenterology, 04/09/08
Print     Email This Article     Save in My Library   Free Abstract
van Soest EM et al. - In a study to investigate the association between the use of proton pump inhibitors (PPI) and the risk of colorectal cancer (CRC), it seems that no association was found between PPI use and the risk of CRC

Methods
  • Cases with CRC were matched with up to 20 controls on age, gender, calendar time, and duration of follow-up prior to diagnosis
  • Cumulative exposure to PPIs was assessed in the 5 yr prior to diagnosis with a 1-yr lag time analysis
  • Adjusted odds ratios (OR) were calculated with 95% confidence intervals using multivariate, conditional logistic regression analysis

Results
  • Within the source population of 457,024 persons, 595 CRC cases were identified
  • The odds of CRC were not increased among pts ever using PPIs compared with pts who never used PPIs
  • Use of PPIs for >365 days was not associated with a greater risk of CRC compared with nonusers
  • The odds of CRC in neither the right nor the left hemicolon were significantly increased in pts using PPIs

Sponsor
Read a Different Specialty
Allergy/Immunology
Anesthesiology
Cardiology
Dermatology
Drugs
Emergency Medicine
Endocrinology
ENT
Family Medicine
Gastroenterology
Hematology-Oncology
Infectious Disease
Internal Medicine
Nephrology
Neurology
OB/Gyn
Ophthalmology
Orthopedics
Pediatrics
Psychiatry
Pulmonology
Radiology
Rheumatology
Surgery
Urology
Profession Index
Dentist
Hospital Administrator
Nurse
    Medical Students
Nurse Practitioner
Pharma/Drug Marketer
    Pharmacist
Physician
Physician Assistants
Article Search
Keyword:
Search:
Published within:
Sort By:
Date Relevance
    
Sponsor
About MDLinx  |  Contact  |  Advertise with MDLinx  |  Site Map  |  Privacy Policy  |  Terms of Use  |  Sign Up For Newsletters  |  Recommend this Site

English |  Español |  Français |  Deutsch |  中文 |  Руccкий |  Norsk |  Nederlands |  Português |  Italiano

©1999-2008 MDLinx, Inc.